(TheNewswire)
Calgary, Alberta - TheNewswire - September 12, 2022 - Ocumetics TechnologyCorp. (“ Ocumetics ” or the “ Company ”)( TSXV:OTC) (OTC:OTCFF) (FRA:2QBO) is pleased toannounce that its common shares have commenced trading on the OTC QBMarket under the symbol "OTCFF". The Company's common shareswill continue to trade on the TSX Venture Exchange under the symbol“OTC” and the Frankfurt Stock Exchange under the symbol“2QBO”.
The Company has listed on the OTC QB Market tofacilitate greater trading visibility and convenience for US-basedinvestors, resulting in more liquidity and greater reach.
“The rapid development of our adaptive intraocularlens technology has caused many US investors to ask us to obtain a USlisting to allow them to purchase Ocumetics stock,” says Dr. MarkLee, CEO of Ocumetics.
“We are pleased to complete this listing and lookforward to increasing our base of US investors and sharing developmentprogress of our accommodating intraocular lens with this group,”adds Dr. Lee.
About Ocumetics
Ocumetics Technology Corp. ( TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO)is a Canadian research and product development company thatspecializes in adaptive lens designs. Ocumetics is in thepreclinical study stage of a game-changing technology for theophthalmic industry. Ocumetics has developed an expandableintraocular lens that fits within the natural lens compartment of theeye potentially to eliminate the need for corrective lenses. It isdesigned to allow the eye’s natural muscle activity to shift focusfrom distance to near.
FOR FURTHER INFORMATION, PLEASECONTACT:
Dr. Mark Lee
President and CEO
(604) 832-6052
Neither the TSXVenture Exchange nor its Regulation Services Provider (as that term isdefined in the policies of the TSX Venture Exchange) acceptsresponsibility for the adequacy or accuracy of this release.
Copyright (c) 2022 TheNewswire - All rights reserved.